Skip to content

Michael Rosenbaum, M.D.

NPI 1285768622ActiveIndividual· Pediatrics, Adolescent Medicine· New York, NY

Pediatrics, Adolescent Medicine (M.D.) in New York, New York, licensed in NY, with an NPI issued in March 2007. Part D covered 14 prescriptions written in 2024. Novo Nordisk Inc reported $82.37 in payments in 2025, mostly food and beverage.

Overview

NPI1285768622
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMar 16, 2007
Last updated in NPPESSep 26, 2013

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)14 · 14 30-day fills
Total drug cost$1,964

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$82.37 · 1 payment from 1 company
  • 2024$124.38 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$82.371

What the 2025 payments were for

  • Food and Beverage$82.37 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Adolescent Medicine providers in New York

All 58 Pediatrics, Adolescent Medicine providers in New York · All Pediatrics, Adolescent Medicine providers in New York